Makoto Ueno Selected Research

Makoto Ueno Research Topics

Disease

74	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 03/2005
52	Neoplasms (Cancer) 05/2024 - 03/2005
31	Biliary Tract Neoplasms (Biliary Tract Cancer) 04/2024 - 07/2012
13	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2017
12	Adenocarcinoma 11/2023 - 09/2015
8	Disease Progression 04/2024 - 12/2017
6	Neoplasm Metastasis (Metastasis) 03/2024 - 03/2011
4	Cholangiocarcinoma 11/2023 - 08/2018
4	Type 2 Diabetes Mellitus (MODY) 06/2018 - 01/2018
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2024 - 01/2016
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2024 - 12/2020
3	Stroke (Strokes) 01/2024 - 01/2019
3	Ascites 08/2022 - 12/2020
3	Anorexia 05/2022 - 01/2018
3	Gastric Outlet Obstruction 02/2022 - 11/2016
3	Febrile Neutropenia 01/2022 - 01/2018
3	Neutropenia 01/2022 - 01/2018
2	Lymphatic Metastasis 12/2023 - 08/2023
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2022
2	Anemia 01/2023 - 11/2016
2	Sarcopenia 10/2022 - 01/2022
2	Thrombocytopenia (Thrombopenia) 05/2022 - 01/2021
2	Exanthema (Rash) 01/2020 - 01/2019
2	Primitive Neuroectodermal Tumors (PNET) 10/2018 - 01/2016
2	Hyperglycemia 06/2018 - 02/2018
2	Chronic Renal Insufficiency 06/2018 - 01/2018
2	Necrosis 12/2017 - 08/2015
1	Carcinogenesis 05/2024
1	Abdominal Pain (Pain, Abdominal) 04/2023

Drug/Important Bio-Agent (IBA)

49	Gemcitabine FDA Link 11/2023 - 04/2012
15	Cisplatin (Platino)FDA LinkGeneric 08/2023 - 07/2012
14	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 01/2018
13	130-nm albumin-bound paclitaxelIBA 04/2023 - 03/2016
11	Leucovorin (Folinic Acid)FDA Link 11/2023 - 01/2018
11	Fluorouracil (Carac)FDA LinkGeneric 11/2023 - 01/2018
11	PlatinumIBA 01/2023 - 02/2017
11	folfirinoxIBA 01/2023 - 01/2018
8	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2011
6	lenvatinibIBA 05/2022 - 01/2020
5	Bevacizumab (Avastin)FDA Link 03/2024 - 08/2018
5	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2018
5	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2019
5	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 02/2018
4	atezolizumabIBA 03/2024 - 08/2021
4	AlbuminsIBA 12/2023 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 09/2023 - 09/2021
4	Epirubicin (Ellence)FDA LinkGeneric 06/2021 - 01/2017
3	pemigatinibIBA 05/2024 - 10/2022
3	C-Reactive ProteinIBA 12/2023 - 01/2020
3	pembrolizumabIBA 01/2023 - 10/2020
3	B7-H1 AntigenIBA 01/2023 - 01/2020
3	PolymersIBA 06/2021 - 01/2017
3	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 06/2018 - 02/2018
3	ORALIT (ORS)IBA 07/2016 - 01/2014
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2024 - 02/2017
2	Carcinoembryonic AntigenIBA 12/2023 - 08/2018
2	AntigensIBA 12/2023 - 05/2022
2	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2023
2	Alanine Transaminase (SGPT)IBA 01/2023 - 05/2022
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2020
2	Monoclonal AntibodiesIBA 01/2023 - 01/2022
2	AntibodiesIBA 05/2022 - 01/2022
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2021
2	ParaffinIBA 01/2022 - 01/2021
2	Circulating Tumor DNAIBA 01/2022 - 12/2020
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2021 - 01/2021
2	BilirubinIBA 02/2021 - 01/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2018 - 06/2013
2	S 1 (combination)IBA 01/2018 - 04/2012
2	Folic Acid (Vitamin M)FDA LinkGeneric 07/2016 - 01/2011
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2024
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2024
1	Antineoplastic Agents (Antineoplastics)IBA 04/2024
1	niraparibIBA 04/2024
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2024
1	CarbohydratesIBA 12/2023
1	Cell-Free Nucleic AcidsIBA 10/2023
1	Immunoconjugates (Immunoconjugate)IBA 09/2023
1	NAD (NADH)IBA 04/2023
1	fibrin fragment D (D-dimer)IBA 04/2023

Therapy/Procedure

57	Drug Therapy (Chemotherapy) 12/2023 - 03/2005
36	Therapeutics 04/2024 - 10/2005
20	Adjuvant Chemotherapy 04/2024 - 12/2014
4	Pancreatectomy 03/2024 - 07/2008
4	Neoadjuvant Therapy 11/2023 - 01/2022
4	Combination Drug Therapy (Combination Chemotherapy) 02/2022 - 01/2018
4	Microspheres (Microsphere) 06/2021 - 08/2015
3	Chemoradiotherapy 08/2023 - 02/2021
3	Stents 02/2022 - 10/2005
3	Pancreaticoduodenectomy 08/2020 - 05/2016
2	Hepatectomy 12/2023 - 01/2021
2	Radioimmunotherapy 09/2023 - 05/2022
2	Radiotherapy 07/2023 - 01/2021
2	Induction Chemotherapy 07/2023 - 02/2021
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 02/2022 - 11/2016
2	Molecular Targeted Therapy 01/2022 - 01/2022
2	Splenectomy 11/2016 - 07/2008
1	Perioperative Care 01/2024
1	Aftercare (After-Treatment) 11/2023